Catalyst Wire Dossier Catalyst Wire Dossier

GLYDO

Lidocaine hydrochloride · Sagent Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GLYDO, covering 2014-04-28 to 2019-10-29. Get the full timeline:

Most recent: FDA Approved: GLYDO — Supplemental Application (Sagent Pharmaceuticals)

See pricing